Home›Companies›Healthcare›StimCardio

StimCardio Medical, Inc.

Develops a wrist-worn device for people with atrial fibrillation.

Updated Nov 11, 2026·Latest SEC filing Jul 29, 2026·Suggest an edit

About StimCardio

StimCardio is a private company based in Los Angeles, California, incorporated in 2025 in Delaware. It has reported $24,949,739 raised in one offering on Form D since July 2026. Its chief executive is Amir Soltianzadeh.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 24, 2025Jul 29, 2026$24,949,739of $25.0M target80$311KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on StimCardio's Form D filed Jul 29, 2026.

JP
Tsahi Holand
Tsahi Holand
Co-Founder and CTO
John Slump
John Slump
Board Member
AZ
Amos Ziv
Founder and CSO, director

Sources

  1. SECStimCardio Medical, Inc. filing history
  2. CompanyPrivacy policy
  3. CompanyAbout StimCardio
  4. CompanyContact StimCardio
  5. PressNeuroPulse pilot study announcement